Chris Dudzinski PhD
Calvin Lammers
Calvin Lammers is a 13-year digital marketing veteran who started his career on the retail side with Target. Calvin made his first foray into eCommerce with Quidsi, an Amazon subsidiary with such sites as Diapers.com and Soap.com. Since then, Calvin has moved over to the brand side leading digital for at a number of F&B disruptor brands such as KIND, Bai, Spindrift, and Health-Ade before making the jump to beauty and personal care with Nécessaire.
At Nécessaire, Calvin oversees digital platforms and media for the personal care brand, including Sephora, Amazon and DTC.
Nathaniel Weiss
Nathaniel is the CEO and Co-Founder of TONE, a fragrance-led personal care brand developed with top Gen Z content creators Kai Cenat + AMP. Previously, he was President of Nécessaire and held various roles at True Religion across product design, merchandising, digital and operations. He started his career at Bain & Co.
Joachim Hernn
Eric Kehoe
Venkatesh Moktali
Generoso Iannicello
Generoso Ianniciello is a strategic leader in life sciences with expertise in multi-omics, diagnostics, biopharma, and platform services. As Chief Business Officer at Anima Biotech, he leads the global strategy for the Biology GPU - a new category in drug discovery infrastructure that connects how AI thinks with how biology works, tackling one of the biggest challenges in the field.
Previously, as CBO at Dante Genomics, he scaled the start-up into a global enterprise with over 200 employees and $100 million in annual revenue. He launched the Dante MyGenome Platform for longevity, personalized medicine, and rare disease diagnostics, and built key partnerships with hospitals, biopharma, and research institutions worldwide.
Generoso Iannicello
Generoso Ianniciello is a strategic leader in life sciences with expertise in multi-omics, diagnostics, biopharma, and platform services. As Chief Business Officer at Anima Biotech, he leads the global strategy for the Biology GPU - a new category in drug discovery infrastructure that connects how AI thinks with how biology works, tackling one of the biggest challenges in the field.
Previously, as CBO at Dante Genomics, he scaled the start-up into a global enterprise with over 200 employees and $100 million in annual revenue. He launched the Dante MyGenome Platform for longevity, personalized medicine, and rare disease diagnostics, and built key partnerships with hospitals, biopharma, and research institutions worldwide.
